NVS

Novartis
NYSE

Real-time Quotes | Nasdaq Last Sale

84.91
-0.08
-0.09%
After Hours: 77.20 -7.71 -9.08% 18:31 05/22 EDT
OPEN
83.85
PREV CLOSE
84.99
HIGH
84.93
LOW
83.51
VOLUME
1.36M
TURNOVER
--
52 WEEK HIGH
99.84
52 WEEK LOW
69.18
MARKET CAP
194.33B
P/E (TTM)
26.29
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average NVS stock price target is 102.67 with a high estimate of 105.00 and a low estimate of 100.00.

EPS

NVS News

More
Tracking David Einhorn's Portfolio - Q1 2020 Update
Seeking Alpha - Article · 2d ago
Whether The Bears Have Read This Pulitzer Prize Winning Historian's Work On The Great Depression
Seeking Alpha - Article · 3d ago
Telehealth is going to 'become the default' for patients: Ro CEO
Yahoo Finance · 3d ago
Here's Why Editas Could Beat Intellia to a CRISPR Therapy
MotleyFool.com · 3d ago
Is Alnylam Pharmaceuticals a Buy?
MotleyFool.com · 4d ago
Legend Biotech Seeks U.S. Capital For Pipeline Advance
Seeking Alpha - Article · 6d ago
Calliditas Therapeutics Seeks U.S. Capital Via IPO
Seeking Alpha - Article · 6d ago
Priced To Perfection: AstraZeneca Is A Sell
Seeking Alpha - Article · 6d ago

Industry

Pharmaceuticals
-0.29%
Pharmaceuticals & Medical Research
+0.05%

Hot Stocks

Symbol
Price
%Change

About NVS

Novartis AG is a holding company, which provides healthcare solutions. The Company is engaged in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. The Company's segments include Innovative Medicines, Sandoz, Alcon and Corporate activities. Innovative Medicines researches, develops, manufactures, distributes and sells patented prescription medicines to develop health outcomes for patients and healthcare providers. Sandoz develops, manufactures, distributes and sells prescription medicines, as well as pharmaceutical active substances that are not protected by valid and enforceable third-party patents. Alcon researches, develops, manufactures, distributes and sells eye care products. Alcon is a provider of eye care with product offerings in eye care devices and vision care. The Company's range of products includes pharmaceuticals and oncology medicines, generic and biosimilar medicines, and eye care devices.
More

Webull offers kinds of Novartis AG (ADR) stock information, including NYSE:NVS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NVS stock news, and many more online research tools to help you make informed decisions.